The effect of Taurine on cognitive and physical functio

Phase 3

• Conditions: .

• Registration Number: IRCT20170326033146N7
• Lead Sponsor: Razi University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2022

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: 15

Inclusion Criteria

Gender
Living in SanandajAge
range 60 to 69 years
BMI 18 to 24 (kg / m2)
Provide valid evidence of complete vaccination of COVID19 and at least three weeks after the second dose
Having the desired level of physical fitness to perform tests based on the Physical Activity Readiness Questionnaire (Q-PAR) and physician approval

Exclusion Criteria

Having any chronic disease
Take any supplement in the two months before the start of the study
Smoking

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Balance. Timepoint: At the beginning of the study and after consuming one and six grams of taurine and a placebo. Method of measurement: Balance is measured using Timed up and go test - TUG.;Muscular endurance. Timepoint: At the beginning of the study and after consuming one and six grams of taurine and a placebo. Method of measurement: Muscular endurance is measured using the 30s chair stand test.;Cardiorespiratory endurance. Timepoint: At the beginning of the study and after consuming one and six grams of taurine and a placebo. Method of measurement: Cardiorespiratory endurance is measured using a 6-min walk test.;Cognitive function. Timepoint: At the beginning of the study and after consuming one and six grams of taurine and a placebo. Method of measurement: Cognitive function is measured using the MMSE test.